Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta

The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 103; no. 5; pp. 2092 - 2101
Main Authors Madrigal, Jose L.M, Kalinin, Sergey, Richardson, Jill C, Feinstein, Douglas L
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.12.2007
Blackwell Publishing Ltd
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Aβ-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ-induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production.
AbstractList The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1‐42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ‐dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co‐incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co‐incubation with NA partially reduced Aβ‐induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ‐glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co‐treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ‐induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production.
The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Abeta) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Abeta-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Abeta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Abeta-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARdelta) agonist. NA also increased expression and activation of PPARdelta. Together these data demonstrate that NA can protect neurons from Abeta-induced damage, and suggest that its actions may involve activation of PPARdelta and increases in GSH production. [PUBLICATION ABSTRACT]
Abstract The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Aβ) 1‐42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Aβ‐dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Aβ did not induce nitrite production from neurons, LDH release was not reduced by co‐incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co‐incubation with NA partially reduced Aβ‐induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of γ‐glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co‐treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARδ) agonist. NA also increased expression and activation of PPARδ. Together these data demonstrate that NA can protect neurons from Aβ‐induced damage, and suggest that its actions may involve activation of PPARδ and increases in GSH production.
The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (A beta ) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. A beta -dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since A beta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced A beta -induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma -glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPAR delta ) agonist. NA also increased expression and activation of PPAR delta . Together these data demonstrate that NA can protect neurons from A beta -induced damage, and suggest that its actions may involve activation of PPAR delta and increases in GSH production.
The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact mechanisms of neuroprotection are not well known. In the current study, we examined neuroprotective effects of NA in primary cultures of rat cortical neurons. Exposure to oligomeric amyloid beta (Abeta) 1-42 peptide induced neuronal damage revealed by increased staining with fluorojade, and toxicity assessed by LDH release. Abeta-dependent neuronal death did not involve neuronal expression of the inducible nitric oxide synthase 2 (NOS2), since Abeta did not induce nitrite production from neurons, LDH release was not reduced by co-incubation with NOS2 inhibitors, and neurotoxicity was similar in wildtype and NOS2 deficient neurons. Co-incubation with NA partially reduced Abeta-induced neuronal LDH release, and completely abrogated the increase in fluorojade staining. Treatment of neurons with NA increased expression of gamma-glutamylcysteine ligase, reduced levels of GSH peroxidase, and increased neuronal GSH levels. The neuroprotective effects of NA were partially blocked by co-treatment with an antagonist of peroxisome proliferator activated receptors (PPARs), and replicated by incubation with a selective PPARdelta (PPARdelta) agonist. NA also increased expression and activation of PPARdelta. Together these data demonstrate that NA can protect neurons from Abeta-induced damage, and suggest that its actions may involve activation of PPARdelta and increases in GSH production.
Author Richardson, Jill C
Kalinin, Sergey
Madrigal, Jose L.M
Feinstein, Douglas L
Author_xml – sequence: 1
  fullname: Madrigal, Jose L.M
– sequence: 2
  fullname: Kalinin, Sergey
– sequence: 3
  fullname: Richardson, Jill C
– sequence: 4
  fullname: Feinstein, Douglas L
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19439827$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17854349$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1DAUhS1URKcDrwAREt0l-DeJkbpAI35VlQV0bTnOdZtRxh7spMw8RN8ZuzNQiRWWJVu-3zn3yucMnTjvAKGC4Iqk9XZdEd6QkhMhK4pxU2Hetm21e4IWfwsnaIExpSXDnJ6isxjXGJOa1-QZOiVNKzjjcoHur2AOfhv8BGYa7qDQ6fAuFt4WzgfdB3B6HBy8K8DaxKSKK27GedLTbQKhiHs33UIcYqFd_yC_09kiO2wh-N0Q_QaK1GIcLAQ9-fCHgr4IYGCbn3oYJ_0cPbV6jPDieC7R9ccPP1afy8tvn76s3l-WRkjRlpaJzlDaMVvXDWtIq6kmWACnHZWApRG2gV72rawB18bUTHeibjurTUMY79gSnR9801Q_Z4iT2gzRwDhqB36OimKBeS1kAl__A679HNKPZKYWgrC0l6g9QCb4GANYtQ3DRoe9IljlvNRa5VhUjkXlvNRDXmqXpC-P_nO3gf5ReAwoAW-OgI5GjzZoZ4b4yEnOZEubxF0cuF_DCPv_HkB9vVrlW9K_Ouit9krfhNTj-jvFhGGc7QVjvwGLWb9w
CODEN JONRA9
CitedBy_id crossref_primary_10_1016_j_pbb_2008_02_011
crossref_primary_10_1007_s12272_010_1017_4
crossref_primary_10_1093_brain_awq362
crossref_primary_10_1111_j_1471_4159_2010_06622_x
crossref_primary_10_1212_WNL_0000000000206736
crossref_primary_10_1016_j_brainres_2017_09_035
crossref_primary_10_1016_j_freeradbiomed_2022_01_022
crossref_primary_10_1016_j_dci_2019_103573
crossref_primary_10_1007_s00441_017_2649_1
crossref_primary_10_1186_1471_2350_11_162
crossref_primary_10_1016_j_neurobiolaging_2014_05_020
crossref_primary_10_1016_j_actbio_2023_01_014
crossref_primary_10_1016_j_neubiorev_2013_05_008
crossref_primary_10_1089_ars_2017_7111
crossref_primary_10_1016_j_neuropharm_2018_08_003
crossref_primary_10_1016_j_nbd_2011_10_026
crossref_primary_10_1038_s41598_019_41756_3
crossref_primary_10_1016_j_nbd_2014_05_019
crossref_primary_10_1016_j_clnesp_2023_06_008
crossref_primary_10_3892_mmr_2018_8378
crossref_primary_10_1016_j_bbi_2018_01_004
crossref_primary_10_1016_j_neuint_2019_104531
crossref_primary_10_1016_j_brainres_2017_12_027
crossref_primary_10_1016_j_neurobiolaging_2019_09_014
crossref_primary_10_1007_s00401_020_02248_1
crossref_primary_10_1016_j_psychres_2013_08_035
crossref_primary_10_3389_fphar_2022_1030609
crossref_primary_10_1111_jnc_13447
crossref_primary_10_1007_s11064_011_0680_2
crossref_primary_10_1016_j_neuint_2013_06_012
crossref_primary_10_1111_j_1471_4159_2012_07673_x
crossref_primary_10_1177_0960327112446840
crossref_primary_10_1016_j_neurobiolaging_2020_12_019
crossref_primary_10_1007_s11682_022_00653_6
crossref_primary_10_1007_s12640_016_9643_3
crossref_primary_10_1155_2013_253210
crossref_primary_10_3390_ijms13045074
crossref_primary_10_3390_ph14040339
crossref_primary_10_1177_1759091418784357
crossref_primary_10_1016_j_npep_2014_11_003
crossref_primary_10_1007_s11011_016_9800_7
crossref_primary_10_1016_j_bbadis_2013_03_006
crossref_primary_10_1016_j_brainresbull_2024_110907
crossref_primary_10_1007_s11064_015_1703_1
crossref_primary_10_1007_s11481_009_9182_2
crossref_primary_10_1186_s40478_017_0411_2
crossref_primary_10_1016_j_bbi_2021_02_030
crossref_primary_10_1155_2008_780452
crossref_primary_10_1016_j_neurobiolaging_2011_04_012
crossref_primary_10_1016_j_neuroscience_2017_12_046
crossref_primary_10_1073_pnas_0909586107
crossref_primary_10_1002_cne_22242
crossref_primary_10_1016_j_ceca_2011_09_002
crossref_primary_10_1016_j_preteyeres_2014_06_001
crossref_primary_10_3233_JAD_190090
crossref_primary_10_1038_s41390_018_0045_5
crossref_primary_10_3389_fneur_2020_00371
crossref_primary_10_1155_2011_373560
crossref_primary_10_1186_1742_2094_7_94
crossref_primary_10_1097_BRS_0b013e3182276d88
crossref_primary_10_1016_j_neulet_2010_01_046
crossref_primary_10_1155_2021_8881770
crossref_primary_10_14336_AD_2019_1125
crossref_primary_10_1038_npp_2011_42
Cites_doi 10.1007/PL00005296
10.1523/JNEUROSCI.22-07-02434.2002
10.1002/jnr.20153
10.1016/j.bbalip.2007.04.018
10.1089/ars.2006.8.873
10.1002/jnr.20394
10.1021/bi0159581
10.1016/S0006-8993(03)02515-0
10.1016/S0891-0618(00)00041-7
10.1016/j.biochi.2004.11.010
10.1016/S0165-5728(99)00192-7
10.1016/0197-4580(95)00066-N
10.1523/JNEUROSCI.5186-05.2006
10.1016/S0736-5748(00)00017-4
10.1002/jnr.20877
10.1046/j.1471-4159.1994.62010372.x
10.1210/mend.14.12.0575
10.1111/j.1471-4159.1993.tb13425.x
10.1124/mol.104.007864
10.1016/j.neuroscience.2006.06.056
10.1111/j.1471-4159.1993.tb13658.x
10.1073/pnas.97.24.13390
10.1089/ars.2006.8.885
10.1016/j.ab.2005.06.010
10.1002/9780470123195.ch7
10.1523/JNEUROSCI.20-18-06862.2000
10.1016/j.brainresrev.2004.02.002
10.1016/S0006-8993(02)03773-3
10.1023/A:1025084415833
10.1523/JNEUROSCI.4042-03.2004
10.1016/j.neurobiolaging.2006.06.003
10.1016/S0140-6736(81)92657-X
10.1016/j.bcp.2005.03.033
10.1111/j.1365-2990.1983.tb00320.x
10.1126/science.2474201
10.1016/j.bbadis.2006.03.002
10.1128/MCB.20.14.5119-5128.2000
10.1016/S0092-8674(00)81664-5
10.1016/j.brainres.2005.12.061
10.1046/j.1471-4159.2001.00556.x
10.1124/jpet.106.115758
10.1128/MCB.20.24.9356-9363.2000
10.1111/j.1460-9568.2005.04427.x
10.1210/me.2002-0020
10.1053/meta.2001.19415
10.1016/0197-4580(95)80002-9
10.1038/sj.jcbfm.9600233
10.1007/s00702-005-0352-y
10.1097/00001756-200007140-00045
10.1271/bbb.61.1646
10.1046/j.1471-4159.2002.01210.x
10.1016/S0196-9781(02)00085-2
10.1016/S0197-0186(02)00049-9
10.1002/jnr.20481
10.1046/j.1471-4159.2003.01909.x
10.1016/0304-3940(93)90135-8
10.1523/JNEUROSCI.21-04-01179.2001
10.1124/mol.64.3.578
10.1016/j.cardiores.2005.10.019
10.1126/science.286.5448.2358
10.1186/1742-2094-1-9
10.1074/jbc.M210207200
10.1023/B:NERE.0000014834.06405.af
10.1016/S0014-2999(02)02789-9
10.1016/S0021-9258(18)68191-8
10.1523/JNEUROSCI.5463-03.2004
10.1046/j.1471-4159.2003.02019.x
10.1097/00001756-199305000-00015
10.3109/00207459408986079
10.1161/01.CIR.0000097003.49585.5E
10.1046/j.1471-4159.2000.0751438.x
10.1523/JNEUROSCI.4998-04.2005
10.1523/JNEUROSCI.4236-05.2006
ContentType Journal Article
Copyright 2008 INIST-CNRS
2007 The Authors Journal Compilation 2007 International Society for Neurochemistry
Copyright_xml – notice: 2008 INIST-CNRS
– notice: 2007 The Authors Journal Compilation 2007 International Society for Neurochemistry
DBID FBQ
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
DOI 10.1111/j.1471-4159.2007.04888.x
DatabaseName AGRIS
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Chemoreception Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList
Virology and AIDS Abstracts
CrossRef

Neurosciences Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1471-4159
EndPage 2101
ExternalDocumentID 1383858661
10_1111_j_1471_4159_2007_04888_x
17854349
19439827
JNC4888
US201300827353
Genre article
Research Support, U.S. Gov't, Non-P.H.S
Journal Article
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29L
2WC
31~
33P
36B
3SF
4.4
41~
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAJUZ
AANLZ
AAONW
AASGY
AAVGM
AAXRX
AAYJJ
AAZKR
ABCQN
ABCUV
ABCVL
ABEML
ABHUG
ABIVO
ABLJU
ABPTK
ABPVW
ABQWH
ABWRO
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOD
ACGOF
ACIWK
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACSMX
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHEFC
AI.
AIACR
AIAGR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FBQ
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GAKWD
GODZA
GX1
H.X
HF~
HH5
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TWZ
UB1
V8K
VH1
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WOW
WQJ
WRC
WUP
WXI
WXSBR
WYISQ
X7M
XG1
XJT
YFH
YNH
YOC
YUY
ZA5
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AHBTC
AITYG
HGLYW
OIG
08R
AAUGY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QR
7TK
7U7
7U9
8FD
C1K
FR3
H94
P64
ID FETCH-LOGICAL-c5958-f35bc22b3f6673718a2a105e42b29e09c5f7ed9d896e06cc63ab568bfac7134b3
IEDL.DBID DR2
ISSN 0022-3042
IngestDate Wed Jul 24 11:49:06 EDT 2024
Thu Oct 10 22:26:28 EDT 2024
Fri Aug 23 01:53:18 EDT 2024
Sun Jul 28 07:06:41 EDT 2024
Sun Oct 22 16:07:46 EDT 2023
Sat Aug 24 00:53:19 EDT 2024
Wed Dec 27 19:27:42 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Peptides
Rat
Alzheimer disease
Toxicity
Activation
Endogenous
Primary culture
Degenerative disease
Alzheimer's disease
Release
Peroxisome proliferator activated receptor
Glutathione
Nervous system diseases
Enzyme
Rodentia
Beta-Amyloid
Nitric-oxide synthase
Cerebral disorder
Vertebrata
Mammalia
Neuron
PPARdelta
Cell death
Central nervous system disease
Neurotransmitter
Oxidoreductases
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5958-f35bc22b3f6673718a2a105e42b29e09c5f7ed9d896e06cc63ab568bfac7134b3
Notes http://dx.doi.org/10.1111/j.1471-4159.2007.04888.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2007.04888.x
PMID 17854349
PQID 206551351
PQPubID 31528
PageCount 10
ParticipantIDs proquest_miscellaneous_20504659
proquest_journals_206551351
crossref_primary_10_1111_j_1471_4159_2007_04888_x
pubmed_primary_17854349
pascalfrancis_primary_19439827
wiley_primary_10_1111_j_1471_4159_2007_04888_x_JNC4888
fao_agris_US201300827353
PublicationCentury 2000
PublicationDate December 2007
PublicationDateYYYYMMDD 2007-12-01
PublicationDate_xml – month: 12
  year: 2007
  text: December 2007
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
– name: New York
PublicationTitle Journal of neurochemistry
PublicationTitleAlternate J Neurochem
PublicationYear 2007
Publisher Oxford, UK : Blackwell Publishing Ltd
Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Oxford, UK : Blackwell Publishing Ltd
– name: Blackwell Publishing Ltd
– name: Blackwell
References 2002; 16
2003; 959
2006b; 26
2006b; 8
2001; 50
2004; 29
1993; 61
1993; 60
2000b; 20
2004; 24
1993; 161
1999; 286
2000a; 18
1983; 9
1988; 263
2006; 1762
2004; 1
1998; 358
2003; 278
2005; 22
1993; 4
2005; 67
1994; 62
2005; 25
2004; 77
2000; 18
2002; 41
2000; 14
2002; 83
2005; 344
2000; 11
2007; 1771
2006; 69
2006; 26
2000; 97
2006a; 28
1999; 99
1994; 79
2005; 70
2003; 86
2003; 87
2005; 79
1997; 61
2003; 458
2003; 975
1995; 16
1981; 1
2007; 320
2004; 45
2000; 20
2006; 8
2005; 87
2005; 81
1999; 100
2001; 21
2006; 113
2003; 108
2006; 84
1989; 245
2002; 23
2000; 75
2002; 22
2006; 142
1999; 73
2001; 79
2003; 64
2006a; 1073–1074
2003; 23
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_60_1
e_1_2_7_17_1
e_1_2_7_62_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_64_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_66_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_68_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_49_1
Shrieve D. C. (e_1_2_7_58_1) 1988; 263
e_1_2_7_73_1
e_1_2_7_50_1
e_1_2_7_71_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_52_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_54_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_56_1
e_1_2_7_37_1
e_1_2_7_39_1
e_1_2_7_6_1
e_1_2_7_4_1
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_61_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_63_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_65_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_67_1
e_1_2_7_48_1
e_1_2_7_69_1
e_1_2_7_27_1
e_1_2_7_29_1
Heneka M. T. (e_1_2_7_28_1) 2000; 20
e_1_2_7_72_1
e_1_2_7_51_1
e_1_2_7_70_1
e_1_2_7_30_1
e_1_2_7_53_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_55_1
e_1_2_7_74_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_57_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_59_1
e_1_2_7_38_1
References_xml – volume: 458
  start-page: 235
  year: 2003
  end-page: 241
  article-title: Propentofylline protects beta‐amyloid protein‐induced apoptosis in cultured rat hippocampal neurons
  publication-title: Eur. J. Pharmacol.
– volume: 84
  start-page: 398
  year: 2006
  end-page: 408
  article-title: Acetyl‐l‐carnitine‐induced up‐regulation of heat shock proteins protects cortical neurons against amyloid‐beta peptide 1‐42‐mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease
  publication-title: J. Neurosci. Res.
– volume: 20
  start-page: 9356
  year: 2000
  end-page: 9363
  article-title: Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta
  publication-title: Mol. Cell. Biol.
– volume: 161
  start-page: 41
  year: 1993
  end-page: 44
  article-title: Toxic effect of a beta‐amyloid peptide (beta 22‐35) on the hippocampal neuron and its prevention
  publication-title: Neurosci. Lett.
– volume: 14
  start-page: 1962
  year: 2000
  end-page: 1975
  article-title: Activation of peroxisome proliferator‐activated receptors (PPARs) by their ligands and protein kinase A activators
  publication-title: Mol. Endocrinol.
– volume: 113
  start-page: 645
  year: 2006
  end-page: 657
  article-title: Lack of glutathione peroxidase‐1 exacerbates Abeta‐mediated neurotoxicity in cortical neurons
  publication-title: J. Neural Transm.
– volume: 67
  start-page: 1882
  year: 2005
  end-page: 1891
  article-title: The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low‐level oxidative stress
  publication-title: Mol. Pharmacol.
– volume: 1
  start-page: 9
  year: 2004
  article-title: Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin‐1beta production
  publication-title: J. Neuroinflammation
– volume: 18
  start-page: 167
  year: 2000a
  end-page: 179
  article-title: Temporal, regional, and cell‐specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide
  publication-title: J. Chem. Neuroanat.
– volume: 22
  start-page: 2434
  year: 2002
  end-page: 2442
  article-title: Noradrenergic depletion potentiates beta ‐amyloid‐induced cortical inflammation: implications for Alzheimer’s disease
  publication-title: J. Neurosci.
– volume: 142
  start-page: 655
  year: 2006
  end-page: 660
  article-title: Amyloid beta‐protein1‐42 increases cAMP and apolipoprotein E levels which are inhibited by beta1 and beta2‐adrenergic receptor antagonists in mouse primary astrocytes
  publication-title: Neuroscience
– volume: 20
  start-page: 5119
  year: 2000
  end-page: 5128
  article-title: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator‐activated receptor beta(delta)
  publication-title: Mol. Cell. Biol.
– volume: 25
  start-page: 2566
  year: 2005
  end-page: 2575
  article-title: Beta‐amyloid‐stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors
  publication-title: J. Neurosci.
– volume: 79
  start-page: 700
  year: 2005
  end-page: 706
  article-title: Gamma‐glutamylcysteine ethyl ester‐induced up‐regulation of glutathione protects neurons against Abeta(1‐42)‐mediated oxidative stress and neurotoxicity: implications for Alzheimer’s disease
  publication-title: J. Neurosci. Res.
– volume: 286
  start-page: 2358
  year: 1999
  end-page: 2361
  article-title: Mediation by a CREB family transcription factor of NGF‐dependent survival of sympathetic neurons
  publication-title: Science
– volume: 75
  start-page: 1438
  year: 2000
  end-page: 1446
  article-title: Overexpression of glutathione peroxidase increases the resistance of neuronal cells to Abeta‐mediated neurotoxicity
  publication-title: J. Neurochem.
– volume: 26
  start-page: 1343
  year: 2006
  end-page: 1354
  article-title: Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice
  publication-title: J. Neurosci.
– volume: 77
  start-page: 240
  year: 2004
  end-page: 249
  article-title: Effect of the peroxisome proliferator‐activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons
  publication-title: J. Neurosci. Res.
– volume: 41
  start-page: 357
  year: 2002
  end-page: 365
  article-title: Noradrenergic regulation of inflammatory gene expression in brain
  publication-title: Neurochem. Int.
– volume: 81
  start-page: 390
  year: 2005
  end-page: 396
  article-title: Norepinephrine protects cortical neurons against microglial‐induced cell death
  publication-title: J. Neurosci. Res.
– volume: 61
  start-page: 1646
  year: 1997
  end-page: 1649
  article-title: Antioxidant effects of dopamine and related compounds
  publication-title: Biosci. Biotechnol. Biochem.
– volume: 28
  start-page: 1206
  year: 2006a
  end-page: 1214
  article-title: Noradrenaline deficiency in brain increases beta‐amyloid plaque burden in an animal model of Alzheimer’s disease
  publication-title: Neurobiol. Aging
– volume: 18
  start-page: 347
  year: 2000
  end-page: 358
  article-title: Neuroprotective effects of estrogens: potential mechanisms of action
  publication-title: Int. J. Dev. Neurosci.
– volume: 26
  start-page: 3345
  year: 2006
  end-page: 3356
  article-title: System Xc‐ and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid‐beta peptide 1–40
  publication-title: J. Neurosci.
– volume: 70
  start-page: 177
  year: 2005
  end-page: 188
  article-title: Receptor‐independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?
  publication-title: Biochem. Pharmacol.
– volume: 263
  start-page: 14107
  year: 1988
  end-page: 14114
  article-title: Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis
  publication-title: J. Biol. Chem.
– volume: 16
  start-page: 2793
  year: 2002
  end-page: 2801
  article-title: Identification of a functional peroxisome proliferator‐activated receptor response element in the rat catalase promoter
  publication-title: Mol. Endocrinol.
– volume: 41
  start-page: 6640
  year: 2002
  end-page: 6650
  article-title: Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662
  publication-title: Biochemistry
– volume: 87
  start-page: 522
  year: 2003
  end-page: 531
  article-title: Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress
  publication-title: J. Neurochem.
– volume: 21
  start-page: 1179
  year: 2001
  end-page: 1188
  article-title: Beta‐amyloid stimulation of microglia and monocytes results in TNFalpha‐dependent expression of inducible nitric oxide synthase and neuronal apoptosis
  publication-title: J. Neurosci.
– volume: 64
  start-page: 578
  year: 2003
  end-page: 586
  article-title: Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes
  publication-title: Mol. Pharmacol.
– volume: 60
  start-page: 1945
  year: 1993
  end-page: 1948
  article-title: Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures
  publication-title: J. Neurochem.
– volume: 45
  start-page: 38
  year: 2004
  end-page: 78
  article-title: Noradrenergic mechanisms in neurodegenerative diseases: a theory
  publication-title: Brain Res. Brain Res. Rev.
– volume: 50
  start-page: 3
  year: 2001
  end-page: 11
  article-title: The ligands/activators for peroxisome proliferator‐activated receptor alpha (PPARalpha) and PPARgamma increase Cu , Zn ‐superoxide dismutase and decrease p22phox message expressions in primary endothelial cells
  publication-title: Metabolism
– volume: 16
  start-page: 661
  year: 1995
  end-page: 674
  article-title: Are reactive oxygen species involved in Alzheimer’s disease?
  publication-title: Neurobiol. Aging
– volume: 20
  start-page: 6862
  year: 2000b
  end-page: 6867
  article-title: Peroxisome proliferator‐activated receptor‐gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death
  publication-title: J. Neurosci.
– volume: 320
  start-page: 1087
  year: 2007
  end-page: 1096
  article-title: Neuroprotective efficacy of the peroxisome proliferator‐activated receptor δ‐selective agonists and
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 16
  start-page: 5
  year: 1995
  end-page: 10
  article-title: Neurotoxicity of A beta amyloid protein is not altered by calcium channel blockade
  publication-title: Neurobiol. Aging
– volume: 1073–1074
  start-page: 460
  year: 2006a
  end-page: 469
  article-title: Peroxisome‐proliferator‐activated receptor‐gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity
  publication-title: Brain Res.
– volume: 1
  start-page: 783
  year: 1981
  end-page: 784
  article-title: Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia
  publication-title: Lancet
– volume: 83
  start-page: 973
  year: 2002
  end-page: 983
  article-title: Microglia enhance beta‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
  publication-title: J. Neurochem.
– volume: 358
  start-page: 582
  year: 1998
  end-page: 585
  article-title: Idebenone protects hippocampal neurons against amyloid beta‐peptide‐induced neurotoxicity in rat primary cultures
  publication-title: Naunyn Schmiedebergs Arch. Pharmacol.
– volume: 24
  start-page: 6799
  year: 2004
  end-page: 6809
  article-title: Beta‐amyloid peptide at sublethal concentrations downregulates brain‐derived neurotrophic factor functions in cultured cortical neurons
  publication-title: J. Neurosci.
– volume: 108
  start-page: 2805
  year: 2003
  end-page: 2811
  article-title: Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator‐activated receptor‐gamma agonist in hypercholesterolemia
  publication-title: Circulation
– volume: 1771
  start-page: 952
  year: 2007
  end-page: 960
  article-title: Modulation of PPAR activity via phosphorylation
  publication-title: Biochim. Biophys. Acta
– volume: 69
  start-page: 440
  year: 2006
  end-page: 449
  article-title: Peroxisome proliferator‐activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress‐induced apoptosis
  publication-title: Cardiovasc. Res.
– volume: 62
  start-page: 372
  year: 1994
  end-page: 375
  article-title: Ca channel blockers attenuate beta‐amyloid peptide toxicity to cortical neurons in culture
  publication-title: J. Neurochem.
– volume: 26
  start-page: 811
  year: 2006b
  end-page: 820
  article-title: 15d‐Prostaglandin J2 activates peroxisome proliferator‐activated receptor‐gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 24
  start-page: 565
  year: 2004
  end-page: 575
  article-title: Beta‐amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase
  publication-title: J. Neurosci.
– volume: 29
  start-page: 637
  year: 2004
  end-page: 650
  article-title: Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress
  publication-title: Neurochem. Res.
– volume: 87
  start-page: 33
  year: 2005
  end-page: 38
  article-title: Phosphorylation of PPARs: from molecular characterization to physiological relevance
  publication-title: Biochimie
– volume: 99
  start-page: 335
  year: 1999
  end-page: 345
  article-title: PPARdelta is an APC‐regulated target of nonsteroidal anti‐inflammatory drugs
  publication-title: Cell
– volume: 97
  start-page: 13390
  year: 2000
  end-page: 13395
  article-title: The neuroprotective effect of pituitary adenylate cyclase‐activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3‐related cysteine protease caspase‐3/CPP32
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 1762
  start-page: 575
  year: 2006
  end-page: 586
  article-title: Anti‐amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease
  publication-title: Biochim. Biophys. Acta
– volume: 975
  start-page: 10
  year: 2003
  end-page: 21
  article-title: Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons
  publication-title: Brain Res.
– volume: 278
  start-page: 11612
  year: 2003
  end-page: 11622
  article-title: characterization of conditions for amyloid‐beta peptide oligomerization and fibrillogenesis
  publication-title: J. Biol. Chem.
– volume: 23
  start-page: 625
  year: 2003
  end-page: 635
  article-title: Intrinsic regulation of brain inflammatory responses
  publication-title: Cell. Mol. Neurobiol.
– volume: 9
  start-page: 3
  year: 1983
  end-page: 19
  article-title: Pathological basis for neurotransmitter changes in Parkinson’s disease
  publication-title: Neuropathol. Appl. Neurobiol.
– volume: 79
  start-page: 200
  year: 2001
  end-page: 210
  article-title: Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress
  publication-title: J. Neurochem.
– volume: 100
  start-page: 156
  year: 1999
  end-page: 168
  article-title: Peroxisome proliferator‐activated receptor gamma agonists protect cerebellar granule cells from cytokine‐induced apoptotic cell death by inhibition of inducible nitric oxide synthase
  publication-title: J. Neuroimmunol.
– volume: 245
  start-page: 417
  year: 1989
  end-page: 420
  article-title: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease
  publication-title: Science
– volume: 73
  start-page: 209
  year: 1999
  end-page: 267
  article-title: The enzymes of glutathione synthesis: gamma‐glutamylcysteine synthetase
  publication-title: Adv. Enzymol. Relat. Areas Mol. Biol.
– volume: 344
  start-page: 8
  year: 2005
  end-page: 15
  article-title: Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands
  publication-title: Anal. Biochem.
– volume: 61
  start-page: 1565
  year: 1993
  end-page: 1568
  article-title: Beta‐amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins
  publication-title: J. Neurochem.
– volume: 8
  start-page: 873
  year: 2006b
  end-page: 883
  article-title: Beta‐amyloid‐dependent expression of NOS2 in neurons: prevention by an alpha2‐adrenergic antagonist
  publication-title: Antioxid. Redox Signal.
– volume: 86
  start-page: 907
  year: 2003
  end-page: 916
  article-title: Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons
  publication-title: J. Neurochem.
– volume: 959
  start-page: 328
  year: 2003
  end-page: 335
  article-title: Prostaglandin E2 rescues cortical neurons from amyloid beta protein‐induced apoptosis
  publication-title: Brain Res.
– volume: 22
  start-page: 2199
  year: 2005
  end-page: 2206
  article-title: Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta‐amyloid exposure
  publication-title: Eur. J. Neurosci.
– volume: 79
  start-page: 185
  year: 1994
  end-page: 190
  article-title: The acute neurotoxic effect of beta‐amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti‐oxidant U‐78517F
  publication-title: Int. J. Neurosci.
– volume: 11
  start-page: 2293
  year: 2000
  end-page: 2297
  article-title: cAMP delays beta‐amyloid (25‐35) induced cell death in rat cortical neurons
  publication-title: Neuroreport
– volume: 4
  start-page: 523
  year: 1993
  end-page: 526
  article-title: Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25–35
  publication-title: Neuroreport
– volume: 8
  start-page: 885
  year: 2006
  end-page: 892
  article-title: Effects of noradrenaline on neuronal NOS2 expression and viability
  publication-title: Antioxid. Redox Signal.
– volume: 23
  start-page: 1471
  year: 2002
  end-page: 1478
  article-title: The neuropeptide PACAP attenuates beta‐amyloid (1‐42)‐induced toxicity in PC12 cells
  publication-title: Peptides
– ident: e_1_2_7_31_1
  doi: 10.1007/PL00005296
– ident: e_1_2_7_29_1
  doi: 10.1523/JNEUROSCI.22-07-02434.2002
– ident: e_1_2_7_59_1
  doi: 10.1002/jnr.20153
– ident: e_1_2_7_8_1
  doi: 10.1016/j.bbalip.2007.04.018
– ident: e_1_2_7_36_1
  doi: 10.1089/ars.2006.8.873
– ident: e_1_2_7_7_1
  doi: 10.1002/jnr.20394
– ident: e_1_2_7_41_1
  doi: 10.1021/bi0159581
– ident: e_1_2_7_69_1
  doi: 10.1016/S0006-8993(03)02515-0
– ident: e_1_2_7_27_1
  doi: 10.1016/S0891-0618(00)00041-7
– ident: e_1_2_7_14_1
  doi: 10.1016/j.biochi.2004.11.010
– ident: e_1_2_7_26_1
  doi: 10.1016/S0165-5728(99)00192-7
– ident: e_1_2_7_5_1
  doi: 10.1016/0197-4580(95)00066-N
– ident: e_1_2_7_55_1
  doi: 10.1523/JNEUROSCI.5186-05.2006
– ident: e_1_2_7_23_1
  doi: 10.1016/S0736-5748(00)00017-4
– ident: e_1_2_7_2_1
  doi: 10.1002/jnr.20877
– ident: e_1_2_7_67_1
  doi: 10.1046/j.1471-4159.1994.62010372.x
– ident: e_1_2_7_40_1
  doi: 10.1210/mend.14.12.0575
– ident: e_1_2_7_16_1
  doi: 10.1111/j.1471-4159.1993.tb13425.x
– ident: e_1_2_7_64_1
  doi: 10.1124/mol.104.007864
– ident: e_1_2_7_32_1
  doi: 10.1016/j.neuroscience.2006.06.056
– ident: e_1_2_7_9_1
  doi: 10.1111/j.1471-4159.1993.tb13658.x
– ident: e_1_2_7_66_1
  doi: 10.1073/pnas.97.24.13390
– ident: e_1_2_7_45_1
  doi: 10.1089/ars.2006.8.885
– ident: e_1_2_7_57_1
  doi: 10.1016/j.ab.2005.06.010
– ident: e_1_2_7_24_1
  doi: 10.1002/9780470123195.ch7
– volume: 20
  start-page: 6862
  year: 2000
  ident: e_1_2_7_28_1
  article-title: Peroxisome proliferator‐activated receptor‐gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-18-06862.2000
  contributor:
    fullname: Heneka M. T.
– ident: e_1_2_7_47_1
  doi: 10.1016/j.brainresrev.2004.02.002
– ident: e_1_2_7_70_1
  doi: 10.1016/S0006-8993(02)03773-3
– ident: e_1_2_7_21_1
  doi: 10.1023/A:1025084415833
– ident: e_1_2_7_3_1
  doi: 10.1523/JNEUROSCI.4042-03.2004
– ident: e_1_2_7_35_1
  doi: 10.1016/j.neurobiolaging.2006.06.003
– ident: e_1_2_7_6_1
  doi: 10.1016/S0140-6736(81)92657-X
– ident: e_1_2_7_18_1
  doi: 10.1016/j.bcp.2005.03.033
– ident: e_1_2_7_46_1
  doi: 10.1111/j.1365-2990.1983.tb00320.x
– ident: e_1_2_7_71_1
  doi: 10.1126/science.2474201
– ident: e_1_2_7_49_1
  doi: 10.1016/j.bbadis.2006.03.002
– ident: e_1_2_7_53_1
  doi: 10.1128/MCB.20.14.5119-5128.2000
– ident: e_1_2_7_25_1
  doi: 10.1016/S0092-8674(00)81664-5
– ident: e_1_2_7_73_1
  doi: 10.1016/j.brainres.2005.12.061
– ident: e_1_2_7_65_1
  doi: 10.1046/j.1471-4159.2001.00556.x
– ident: e_1_2_7_34_1
  doi: 10.1124/jpet.106.115758
– ident: e_1_2_7_43_1
  doi: 10.1128/MCB.20.24.9356-9363.2000
– ident: e_1_2_7_15_1
  doi: 10.1111/j.1460-9568.2005.04427.x
– ident: e_1_2_7_22_1
  doi: 10.1210/me.2002-0020
– ident: e_1_2_7_33_1
  doi: 10.1053/meta.2001.19415
– ident: e_1_2_7_68_1
  doi: 10.1016/0197-4580(95)80002-9
– ident: e_1_2_7_74_1
  doi: 10.1038/sj.jcbfm.9600233
– ident: e_1_2_7_12_1
  doi: 10.1007/s00702-005-0352-y
– ident: e_1_2_7_51_1
  doi: 10.1097/00001756-200007140-00045
– ident: e_1_2_7_72_1
  doi: 10.1271/bbb.61.1646
– ident: e_1_2_7_54_1
  doi: 10.1046/j.1471-4159.2002.01210.x
– ident: e_1_2_7_50_1
  doi: 10.1016/S0196-9781(02)00085-2
– ident: e_1_2_7_17_1
  doi: 10.1016/S0197-0186(02)00049-9
– ident: e_1_2_7_44_1
  doi: 10.1002/jnr.20481
– ident: e_1_2_7_37_1
  doi: 10.1046/j.1471-4159.2003.01909.x
– ident: e_1_2_7_61_1
  doi: 10.1016/0304-3940(93)90135-8
– ident: e_1_2_7_11_1
  doi: 10.1523/JNEUROSCI.21-04-01179.2001
– ident: e_1_2_7_48_1
  doi: 10.1124/mol.64.3.578
– ident: e_1_2_7_52_1
  doi: 10.1016/j.cardiores.2005.10.019
– ident: e_1_2_7_56_1
  doi: 10.1126/science.286.5448.2358
– ident: e_1_2_7_13_1
  doi: 10.1186/1742-2094-1-9
– ident: e_1_2_7_60_1
  doi: 10.1074/jbc.M210207200
– ident: e_1_2_7_10_1
  doi: 10.1023/B:NERE.0000014834.06405.af
– ident: e_1_2_7_38_1
  doi: 10.1016/S0014-2999(02)02789-9
– volume: 263
  start-page: 14107
  year: 1988
  ident: e_1_2_7_58_1
  article-title: Heterogeneity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)68191-8
  contributor:
    fullname: Shrieve D. C.
– ident: e_1_2_7_63_1
  doi: 10.1523/JNEUROSCI.5463-03.2004
– ident: e_1_2_7_42_1
  doi: 10.1046/j.1471-4159.2003.02019.x
– ident: e_1_2_7_20_1
  doi: 10.1097/00001756-199305000-00015
– ident: e_1_2_7_39_1
  doi: 10.3109/00207459408986079
– ident: e_1_2_7_62_1
  doi: 10.1161/01.CIR.0000097003.49585.5E
– ident: e_1_2_7_4_1
  doi: 10.1046/j.1471-4159.2000.0751438.x
– ident: e_1_2_7_19_1
  doi: 10.1523/JNEUROSCI.4998-04.2005
– ident: e_1_2_7_30_1
  doi: 10.1523/JNEUROSCI.4236-05.2006
SSID ssj0016461
Score 2.22935
Snippet The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact...
Abstract The endogenous neurotransmitter noradrenaline (NA) can protect neurons from the toxic consequences of various inflammatory stimuli, however the exact...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
fao
SourceType Aggregation Database
Index Database
Publisher
StartPage 2092
SubjectTerms Adult and adolescent clinical studies
Alzheimer disease
Alzheimer’s disease
Amyloid beta-Peptides - toxicity
Animals
Beta-Amyloid
Biological and medical sciences
Brain
Cell Survival - drug effects
Cerebral Cortex
Chemistry
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Embryo, Mammalian
Fluoresceins
Gene Expression Regulation - drug effects
Glutamic Acid - metabolism
Glutathione - metabolism
L-Lactate Dehydrogenase - metabolism
Medical sciences
Mice
Mice, Knockout
Neurology
neuron
Neurons
Neurons - drug effects
Neuroprotective Agents
Neurosciences
Neurotransmitters
Nitric Oxide Synthase Type II - deficiency
Norepinephrine - pharmacology
Organic Chemicals
Organic mental disorders. Neuropsychology
Peptide Fragments - toxicity
PPAR delta - metabolism
PPARdelta
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Rats
Rodents
Transfection - methods
Title Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1471-4159.2007.04888.x
https://www.ncbi.nlm.nih.gov/pubmed/17854349
https://www.proquest.com/docview/206551351
https://search.proquest.com/docview/20504659
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagF7jwaIGGQvEBccsqieM44VYtrMpK9ACs1Fs0flVVabIiu1LLf-A_M-MkW7bqASEuq2hjj2Lnm4cn82DsbQUVpF6ZOIFExHmWiliXpoi9wRk5VIkProHPJ8XxIp-fytMh_olyYfr6EBuHG3FGkNfE4KC7W0yu8PyD-nioRIhYLCdkT6ZCUXTXhy-bSlJURSvdFA5HoG4H9dxJaEtT3ffQUtwkdLh1vu95cZdRum3jBiU1e8wuxuX1sSkXk_VKT8zPW5Uf_8_6n7BHgy3Lj3rwPWX3XLPL9o4aPMdfXvN3PESXBrf9LnswHTvL7bFfoSLIUCECpS3vkys63nreICQpuRzoAd_zIdyEtw0_Qx6hUMm2cby7btBw7c47Do0N03vPMlGgyudX51176fiSWhJ5FyIJxlHOchTybkl_Wfd9Bc_YYvbx2_Q4HtpCxEZWsoy9kNpkmRaeWpaiboUM0Ep0eaazyiWVkV45W9myKlxSGFMI0LIotQdDibNaPGc7DT7rPuNWZ9oqCyJzqDEgBweiKEFbIUxpQUUsHSFQL_vqH_WfpyaV1rT_1MtT1WH_66uI7SNWajhDIV0vvmb0aRjtLCWkiNjhFoBuaFZoF-KYiB2MiKoHWdIh8YK68Mg0Ym82d_GN0ZcdaFy7piEyyQtZRexFD8Mbyqqk5GG8UwQw_fUy6vnJlK5e_uvEA_Yw-MFD6M8rtrP6sXav0YBb6cPAmvg7-zT_DUIlOns
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELWgHMqFjxZoKLQ-IG5ZJXHsJNyqhWop7R6gK_UWjR27qmiTFdmVWv4D_5kZJ9myVQ8IcVtt7FHivBmPJzNvGHtXQAGxy0wYQSTCNIlFqHOjQmdwRgpF5Hxo4GSqJrP06Eye9e2AqBam44dYBdxIM7y9JgWngPQdLc_wAIQbck9FiGDMR-hQPkLtF9TO4OPXFZcU8WjFK-pwhOp6Ws-9ktb2qocOGsqchBYXz3VdL-5zS9e9XL9NHT5ll8MDdtkp30fLhR6Zn3e4H__TCjxjT3p3lh90-HvOHth6i20f1HiUv7rh77lPMPWR-y22OR6ay22zX54UpCeJQIPLu_qKljeO14hKqi8HusMPvM844U3Nz1FNKFuyqS1vb2r0XduLlkNd-eldcJkkEPn59UXbXFk-p65EzvpkgmGUrTjaeTunvyp7uYAXbHb46XQ8CfvOEKGRhcxDJ6Q2SaKFo66luL1CAugo2jTRSWGjwkiX2aqo8kLZSBmjBGipcu3AUO2sFi_ZRo33usN4pRNdZRWIxOKmASlYECoHXQlh8gqygMUDBsp5RwBS_nlwyuKS1p_aeWalX__yOmA7CJYSztFOl7NvCX0dRlcrE1IEbG8NQbcyC3QNcUzAdgdIlb05aVG4okY8Mg7Y_uoqvjH6uAO1bZY0REapkkXAXnU4vJWc5VQ_jFeUR9NfP0Z5NB3Tr9f_OnGfbU5OT47L48_TL7vssQ-L-0ygN2xj8WNp36I_t9B7Xk9_A2ZuPZs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BkYALj5ZSU2j3gLg5sr322uZWpUSlQISASL1Zs6-qKrUjnEgt_4H_zMzaTknVA0Lconh3ZK_ntetvvmHsdQklxC7XYQSRCNMkFqEqtAydxhkplJHzRwOfpvJolh6fZCc9_olqYTp-iNWBG1mG99dk4HPjbhh5jvsfjMc9EyHqYjHCfPJeKkVE8K7DLysqKaLRilfM4aip66ieWyWthaq7DhoCTkKLa-e6phe3ZaXrSa6PUpPH7Hx4vg6ccj5aLtRI_7xB_fh_FuAJe9Qns_yg076n7I6tN9nWQY0b-Ysr_oZ7eKk_t99kD8ZDa7kt9stTgvQUEehueVdd0fLG8Rp1kqrLgW7wLe_xJryp-SkaCWElm9ry9qrGzLU9aznUxk_vjpZJAlGfX561zYXlc-pJ5KyHEgyjrOHo5e2c_jL2-wKesdnk3bfxUdj3hQh1VmZF6ESmdJIo4ahnKQZXSADTRJsmKiltVOrM5daUpiiljaTWUoDKZKEcaKqcVWKbbdR4rzuMG5UokxsQicWQASlYELIAZYTQhYE8YPGgAtW8o_-o_tw25XFF60_NPPPKr391GbAd1JUKTtFLV7OvCX0bxkQrF5kI2N6aAl3LLDExxDEB2x00quqdSYvCJbXhyeKA7a-u4hujTztQ22ZJQ7IolVkZsOedGl5LzguqHsYr0ivTXz9GdTwd068X_zpxn93_fDipPr6ffthlD_2ZuIcBvWQbix9L-wqTuYXa81b6G3NjPEo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuroprotective+actions+of+noradrenaline%3A+effects+on+glutathione+synthesis+and+activation+of+peroxisome+proliferator+activated+receptor+delta&rft.jtitle=Journal+of+neurochemistry&rft.au=Madrigal%2C+Jose+L.M&rft.au=Kalinin%2C+Sergey&rft.au=Richardson%2C+Jill+C&rft.au=Feinstein%2C+Douglas+L&rft.date=2007-12-01&rft.pub=Oxford%2C+UK+%3A+Blackwell+Publishing+Ltd&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=103&rft.issue=5&rft.spage=2092&rft.epage=2101&rft_id=info:doi/10.1111%2Fj.1471-4159.2007.04888.x&rft.externalDocID=US201300827353
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon